NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
ID: 358863Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358863

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-25-445.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for the NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional) aimed at advancing the diagnosis, prevention, treatment, and amelioration of human sensory and communication disorders. This funding opportunity supports integrated, multidisciplinary research programs that include 3-4 synergistic research projects and an administrative core, with the possibility of 1-2 optional scientific cores, all centered around a unifying clinical theme. The maximum project period is five years, with budgets capped at $1,500,000 in direct costs per year for new applications. Eligible applicants include various organizations, excluding foreign entities, and are encouraged to consult with NIDCD staff prior to submission to ensure responsiveness. The application deadline is June 2, 2028, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-25-445-Full-Announcement.html
    PAR-25-445.html
    The National Institute on Deafness and Other Communication Disorders (NIDCD) invites applications for Clinical Research Center Grants (P50 Clinical Trial Optional) to advance the diagnosis, prevention, treatment, and amelioration of human sensory and communication disorders, specifically those related to hearing, balance, smell, taste, voice, speech, or language. This funding opportunity, PAR-25-445, supports integrated, multidisciplinary research programs comprising 3-4 synergistic research projects and an administrative core, with 1-2 optional scientific cores, all focused on a unifying clinical theme. Applications must primarily involve individuals with sensory and/or communication disorders or their data/tissues, though limited departures are possible with strong justification. Low-risk clinical trials are optional. Applicants are strongly encouraged to consult with NIDCD staff prior to submission, as non-responsive or incomplete applications will not be reviewed. The maximum project period is five years, with budgets for new applications capped at $1,500,000 direct costs per year. Eligible applicants include various organizations, but foreign organizations are not eligible. Review criteria emphasize overall impact, the cohesiveness and synergy of projects, and the multidisciplinary approach, along with standard considerations for human subjects, vertebrate animals, and budget justification.
    Similar Opportunities
    NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a Clinical Research Center Grant (P50 Clinical Trial Optional) aimed at advancing research in the areas of hearing, balance, smell, taste, voice, speech, or language. This grant encourages small businesses to form multidisciplinary teams that will collaborate on a synergistic set of 3-4 research projects addressing a unifying theme related to sensory and communication disorders. The initiative is designed to foster innovative solutions to complex clinical problems through integrated research efforts, supported by an administrative core and optional scientific cores. Interested applicants should note that while applications are not currently being solicited, they are encouraged to prepare for the upcoming Notice of Funding Opportunity (NOFO), with an estimated synopsis posting date of August 6, 2025, and a close date of October 7, 2025. For further inquiries, potential applicants can contact Holly Storkel, Ph.D., at holly.storkel@nih.gov or by phone at 301-496-5061.
    NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Deafness and Other Communication Disorders (NIDCD) for cooperative agreements aimed at supporting clinical trials in communication disorders. Applicants are required to propose a single clinical trial that may necessitate FDA oversight, demonstrate efficacy, or involve higher risks, with an emphasis on substantial interaction with NIDCD staff and comprehensive protections for human subjects. This initiative is crucial for advancing research and establishing effective treatments for conditions related to hearing, balance, taste, smell, voice, speech, and language. Interested applicants can access further details and guidelines through the announcement available at NIH Grants, with a budget that may exceed $700,000 in specific circumstances and a closing date for applications set for October 18, 2027.
    NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is offering a funding opportunity titled "NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)." This initiative aims to support cooperative agreements for clinical trials that require FDA oversight, are intended to establish efficacy, or present higher risks to participants, with a budget exceeding $700,000. The funding is crucial for advancing clinical practices in treating communication disorders, emphasizing the inclusion of diverse populations in recruitment and retention strategies. Interested applicants, including various educational and nonprofit organizations, must submit their applications by January 27, 2024, and can find more information at NIH Grants.
    NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), is offering research grants aimed at translating basic research findings into clinical practice, specifically for communication disorders. This funding opportunity encourages collaborations between basic scientists and clinicians to develop practical applications that address hearing, balance, smell, taste, voice, and language disorders, with a focus on milestone-driven proposals that demonstrate a clear connection to clinical conditions and impactful outcomes. The grants, limited to a maximum of $500,000 in direct costs annually, are expected to support 2-3 awards in FY25, with applications due by October 12, 2027. Interested applicants can find more information and submit their proposals through Grants.gov, and may contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity for low-risk clinical trials in communication disorders under Funding Opportunity Number PAR-24-051. This initiative aims to support investigator-initiated projects that develop effective interventions in areas such as hearing, speech, and language, specifically targeting low-risk clinical trials that do not require FDA oversight and adhere to budget limits of under $500,000 in direct costs per year. The funding is particularly significant for enhancing research in communication disorders, ultimately improving public health outcomes through scientifically validated interventions. Interested applicants can submit proposals starting January 5, 2024, with the opportunity closing on January 8, 2028; for further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NIDCD Research Opportunities for New Investigators to Promote Workforce Development (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Deafness and Other Communication Disorders (NIDCD) to support R01 grant applications aimed at promoting workforce development among Early Stage and New Investigators in the field of communication disorders. This initiative encourages applications from individuals from diverse backgrounds, particularly those underrepresented in health-related sciences, and allows for innovative research projects without the necessity of preliminary data, provided they demonstrate feasibility. Applicants can request up to $500,000 in direct costs per year, with a total funding commitment of approximately $2.1 million planned for fiscal years 2026 and 2027 to support around 7-8 meritorious projects. Key application dates begin on January 6, 2025, with a closing date of October 6, 2026; for further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDCD Early Career Research (ECR) Award (R21 Clinical Trial Optional) to support novice researchers in establishing independent careers in biomedical and behavioral sciences, specifically in areas related to hearing, balance, smell, taste, voice, speech, or language. This grant mechanism allows for various research projects, including secondary data analysis and translational research, but cannot be utilized for thesis or dissertation work. The award aims to generate preliminary data to support future R01 applications, with a total funding of up to $375,000 over three years, and applications are due beginning January 19, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-120.html.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)" aimed at stimulating research related to HIV/AIDS within the National Institute on Deafness and Other Communication Disorders (NIDCD). This initiative encourages applications that address high-priority research areas identified by the NIH Office of AIDS Research, particularly focusing on the intersections of HIV/AIDS with hearing, communication, and associated disorders. Grants of up to $499,999 in direct costs are available for projects lasting up to five years, with no cost-sharing or matching requirements. Interested applicants, including educational institutions and community organizations, must adhere to NIH guidelines and submit their proposals through Grants.gov by the closing date of January 7, 2028. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)." This grant aims to stimulate innovative research addressing critical issues related to communication disorders—such as hearing, balance, taste, smell, voice, speech, and language—specifically for individuals living with HIV/AIDS. The initiative encourages multidisciplinary collaborations and supports low-risk clinical trials that do not require FDA oversight, with a total funding limit of $275,000 for two-year projects, and no more than $200,000 in any single year. Interested applicants, including various academic institutions and nonprofits, must submit their proposals by January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDCD Early Career Research (ECR) Award (R21 Clinical Trial Optional) to support emerging researchers in establishing independent careers in biomedical and behavioral research related to hearing, balance, smell, taste, voice, speech, or language. This grant allows for various project types, including secondary data analysis, small research initiatives, and the development of research methodologies or technologies, with the goal of generating preliminary data for future R01 applications. Eligible applicants include a diverse range of institutions, particularly those serving underrepresented groups, and may request up to $375,000 in direct costs over a three-year period. Applications are due by February 17, 2027, and interested parties can find more information and submission guidelines at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov.